Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Vaccines and Guillain-Barré syndrome.

Haber P, Sejvar J, Mikaeloff Y, DeStefano F.

Drug Saf. 2009;32(4):309-23. doi: 10.2165/00002018-200932040-00005. Review.

PMID:
19388722
2.

Guillain-Barré syndrome following influenza vaccination.

Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT.

JAMA. 2004 Nov 24;292(20):2478-81.

PMID:
15562126
3.
4.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

5.

Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Oct 20;55(41):1120-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2006 Nov 3;55(43):1177.

6.

Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).

Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, Menkes DL, Qureshi AI.

J Clin Neuromuscul Dis. 2012 Dec;14(2):66-71. doi: 10.1097/CND.0b013e31824db14e.

PMID:
23172385
7.

Influenza vaccination and Guillain Barre syndrome.

Geier MR, Geier DA, Zahalsky AC.

Clin Immunol. 2003 May;107(2):116-21.

PMID:
12763480
8.

Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.

Velentgas P, Amato AA, Bohn RL, Chan KA, Cochrane T, Funch DP, Dashevsky I, Duddy AL, Gladowski P, Greenberg SA, Kramer JM, McMahill-Walraven C, Nakasato C, Spettell CM, Syat BL, Wahl PM, Walker AM, Zhang F, Brown JS, Platt R.

Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1350-8. doi: 10.1002/pds.3321. Epub 2012 Jul 16.

PMID:
22807266
9.

Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign.

Deeks SL, Lim GH, Simpson MA, Rosella L, Mackie CO, Achonu C, Crowcroft NS.

BMC Public Health. 2011 May 17;11:329. doi: 10.1186/1471-2458-11-329.

10.

Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.

Vellozzi C, Iqbal S, Broder K.

Clin Infect Dis. 2014 Apr;58(8):1149-55. doi: 10.1093/cid/ciu005. Epub 2014 Jan 9. Review.

PMID:
24415636
11.

Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Apr 7;55(13):364-6.

12.

Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001.

Burwen DR, Ball R, Bryan WW, Izurieta HS, La Voie L, Gibbs NA, Kliman R, Braun MM.

Am J Prev Med. 2010 Oct;39(4):296-304. doi: 10.1016/j.amepre.2010.05.022.

PMID:
20837279
13.

Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).

Souayah N, Yacoub HA, Khan HM, Michas-Martin PA, Menkes DL, Maybodi L, Qureshi AI.

Neuroepidemiology. 2012;38(4):227-32. doi: 10.1159/000336113. Epub 2012 Apr 27.

14.

Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.

Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE, Manuel DG, Moineddin R, Wilson K.

Arch Intern Med. 2006 Nov 13;166(20):2217-21.

PMID:
17101939
15.

Recurrent Guillain-Barre syndrome following vaccination.

Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; CISA Network.

Clin Infect Dis. 2012 Mar;54(6):800-4. doi: 10.1093/cid/cir960. Epub 2012 Jan 19.

PMID:
22267712
16.

Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?

Nelson KE.

Am J Epidemiol. 2012 Jun 1;175(11):1129-32. doi: 10.1093/aje/kws194. Epub 2012 May 11.

PMID:
22582208
17.

Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.

Iqbal S, Li R, Gargiullo P, Vellozzi C.

Vaccine. 2015 Apr 21;33(17):2045-9. doi: 10.1016/j.vaccine.2015.02.064. Epub 2015 Mar 4.

PMID:
25749247
18.

Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA.

Souayah N, Yacoub HA, Khan HM, Farhad K, Maybodi L, Qureshi AI, Menkes DL.

J Clin Neurosci. 2012 Aug;19(8):1089-92. doi: 10.1016/j.jocn.2011.11.022. Epub 2012 Jun 15.

PMID:
22705140
19.

Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Israeli E, Agmon-Levin N, Blank M, Chapman J, Shoenfeld Y.

Clin Rev Allergy Immunol. 2012 Apr;42(2):121-30. doi: 10.1007/s12016-010-8213-3. Review.

PMID:
20890797
20.

Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.

Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, Day T, Gates P, Macdonell R, Roberts L, Rodriguez-Casero V, Wijeratne T, Kiers L.

Med J Aust. 2012 Nov 19;197(10):574-8. Erratum in: Med J Aust. 2014 Apr 7;200(6):321. Macdonnell, Richard [corrected to Macdonell, Richard].

PMID:
23163689

Supplemental Content

Support Center